DTC Ads Reference To Alternative Treatments Urged In Health Affairs Article
This article was originally published in The Tan Sheet
Executive Summary
FDA should require that direct-to-consumer advertisements for pharmaceuticals mention alternative treatments "by name or at least by class," an article in the March/April issue of Health Affairs states.